Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 52.51

+2.7%

Nov 14 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (64)	3/16/1999 10:26:00 PM
From: LLCF	Read Replies (2) of 52153

<At a glance, looks like you slipped a decimal for SIBI - I believe they have under 10m shares outstanding.> Yes, you're right of course... which would mean SIBI's cash is 50% of the market cap. I think some surprises to me include ALKS, and MLNM... especially seeing ALKS trade at $24 recently, and MLNM $28. Here's something on the newswires tonight that might effect BTRN someday? biz.yahoo.com If I hadn't just bought some SIBI @ 4.25 recently I'd buy more... one of these days these things will run away, and if you don't have 'em you may have to chase. I think CORR is interesting here... I bought some more today. We have an approved product which depending on sales may turn out to be worth quite a bit more than the extra 25% of mkt cap you get in cash with the real cheap stuff... I follow this one and will post on intergrelin if anyone cares. In the meantime an opinion from MTSL to spice things up for potential CORR buyers: Message 8331825 DAK

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next